More on ABVX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.2 Score)

Upcoming Events

- Earnings (9/21/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Abivax (NQ:ABVX)
Delayed: 111.73 -1.62 (1.43%)
Prev. Close $113.35  
Open$112.17 
52 Wk High$ 
52 Wk Low$ 
Day High$114.33 
Day Low$111.36 
P/E N/A  
EPS$ 
Volume1,056,739 

Friends, Peers and Foes (?): AAVXF, LLY, CYTK, RAPP, RYTM (more...)

Aug 14, 2026 04:31 PM Form SCHEDULE 13G/A Abivax S.A. Filed by: TCG Crossover GP I, LLC
Aug 13, 2026 10:55 AM Form SCHEDULE 13G/A Abivax S.A. Filed by: Invus Global Management, LLC
Jul 30, 2026 04:07 PM Abivax completes pre-NDA meeting with FDA for ulcerative colitis drug
Jul 30, 2026 04:05 PM Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
Jul 24, 2026 09:38 AM Abivax (ABVX) PT Raised to $180 at Morgan Stanley
Jul 23, 2026 04:06 PM Abivax names four commercial leaders ahead of planned NDA filing
Jul 23, 2026 04:05 PM Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
Jul 9, 2026 07:11 AM Abivax (ABVX) PT Raised to $175; Piper Sandler: 'We remain buyers here'
Jul 6, 2026 09:36 PM Form SCHEDULE 13D/A Abivax S.A. Filed by: Sofinnova Crossover I
Jul 2, 2026 04:10 PM Form 6-K Abivax S.A. For: Jul 02
View All Articles

Entities mentioned with ABVX

View All Entities